Product Overview
Tesamorelin: Targeted Visceral Fat Reduction & Metabolic Optimizer
Why Tesamorelin is of special interest: Excess stubborn abdominal (visceral) fat and metabolic slowdown are common with aging or hormonal decline. Tesamorelin’s longevity value lies in its ability to naturally stimulate the body’s own growth hormone release in a pulsatile manner, specifically targeting and supporting the clearance of deep visceral fat within the body.
Potential Benefits Shown in Early Limited Evaluations
Clinical trials and research suggest:
-
Significant reduction in visceral adipose tissue, up to nearly 20% in 26 weeks.
-
Improved body composition with reductions in waist circumference and liver fat.
-
Reduction of visceral fat while significantly minimizing muscle loss, as often seen in dieting.
-
Support for metabolic health markers, including improved lipid profiles.
-
Possible secondary benefits for energy and recovery, especially when stacked with other supportive peptides.
Note: Tesamorelin has been discussed in stacks with other peptides (such as BPC‑157 for gut and inflammation support). These combinations may potentially provide enhanced results depending on the research indication. Tesamorelin is FDA‑approved for reducing excess abdominal fat in HIV‑infected adults with lipodystrophy; however, use for general anti‑aging or fat loss is considered off‑label.
What Tesamorelin Is
Tesamorelin is a 44‑amino‑acid synthetic peptide analog of human Growth Hormone‑Releasing Hormone (GHRH). It includes an N‑terminal trans‑3‑hexenoyl modification that improves stability.
How It Works (Mechanism of Action)
Tesamorelin binds to GHRH receptors on the anterior pituitary gland, stimulating the pulsatile release of endogenous growth hormone (GH). This increases IGF‑1 production and promotes targeted lipolysis in visceral fat.
Backed by Science
-
Multiple Phase 3 randomized, placebo‑controlled trials demonstrated consistent reductions in visceral fat of 15–18% over 26 weeks.
-
Research confirms Tesamorelin activates the GHRH/GH/IGF‑1 axis with a more natural secretion pattern than direct GH therapy.
Disclaimer
Peptides are sold for laboratory research use only. They are not for human, medical, or veterinary use. Buyers must be qualified to handle research materials and assume full responsibility for their safe use.